Alpha Tau Medical Ltd.DRTS stock score: 30/100

$11.31 · -5.83% · Scored Nov 19, 2026

Technical
47
Fundamental
26
News
58

The reading

Alpha Tau Medical (DRTS) scores 30 out of 100, which reads bearish, higher than 4% of Healthcare stocks and 6% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 26, technicals 47.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Quality (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 27 and contrarian oscillators 70 — a split worth reading before trusting the technical total.

News sentiment is neutral at 58; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 30 to 48, and it is down 18 points over the period.

About Alpha Tau Medical

Alpha Tau Medical (DRTS) is an Israel-based medical device company developing Alpha DaRT, a cancer treatment that delivers alpha radiation directly inside solid tumors. Small radioactive sources implanted in the tumor release atoms that diffuse a short distance and emit alpha particles meant to destroy cancer cells while limiting harm to healthy tissue. Alpha DaRT is approved for commercial use in Israel, and the company is pursuing FDA approval for recurrent cutaneous squamous cell carcinoma, an indication that holds Breakthrough Device Designation. Clinical programs cover pancreatic cancer, recurrent glioblastoma and skin cancer in immunocompromised patients. The company has a collaboration with Tolmar to develop and commercialize Alpha DaRT for prostate cancer in the United States. Alpha Tau has little product revenue and funds its work mainly through capital raises and partnership payments.

Alpha DaRT competes with established cancer treatments, including external beam radiation, conventional brachytherapy, surgery and drug therapies, and with other developers of targeted alpha therapies. Its edge rests on an approach that places alpha emitters inside the tumor and on clinical data gathered across several tumor types. Investors who follow DRTS stock tend to watch regulatory decisions in the United States and Japan and data from the pancreatic, brain and skin cancer trials. Progress under the Tolmar collaboration is closely followed. Cash runway and manufacturing scale-up are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward DRTS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

26

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • How often the company beat analysts' EPS estimates over recent quarters, by how much, and the trend in reported EPS from quarter to quarter.

  • How reliably yearly earnings grow: the share of years with higher earnings, the compound growth rate, how steady that growth is, and the last two yearly changes.

  • Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.

26 weighted scorers; 13 had no data today and are left out rather than counted as zero.

Technical · daily

35

Pulling it up

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • The price change over the last 52 weeks.

Holding it back

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Simple Moving Average (10-period) smooths price action over 10 periods.

  • Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
58

Technical score by timeframe

ChartScoreWeight
Hourly321
Daily353
Weekly532
Monthly672

Composite score, last 90 days

05010030Aug 23, 2026Nov 19, 2026Aug 23, 2026: 48Aug 24, 2026: 48Aug 25, 2026: 47Aug 26, 2026: 48Aug 27, 2026: 48Aug 28, 2026: 46Aug 29, 2026: 47Aug 30, 2026: 47Aug 31, 2026: 45Sep 1, 2026: 46Sep 2, 2026: 47Sep 4, 2026: 47Sep 5, 2026: 48Sep 6, 2026: 48Sep 7, 2026: 48Sep 8, 2026: 48Sep 9, 2026: 45Sep 10, 2026: 46Sep 11, 2026: 46Sep 12, 2026: 46Sep 13, 2026: 46Sep 14, 2026: 45Sep 15, 2026: 47Sep 16, 2026: 47Sep 17, 2026: 48Sep 18, 2026: 47Sep 19, 2026: 47Sep 20, 2026: 47Sep 21, 2026: 48Sep 22, 2026: 46Sep 23, 2026: 47Sep 24, 2026: 46Sep 25, 2026: 45Sep 26, 2026: 46Sep 27, 2026: 46Sep 28, 2026: 47Sep 29, 2026: 48Sep 30, 2026: 46Oct 1, 2026: 44Oct 2, 2026: 45Oct 3, 2026: 45Oct 4, 2026: 45Oct 5, 2026: 46Oct 6, 2026: 46Oct 7, 2026: 44Oct 8, 2026: 43Oct 9, 2026: 45Oct 10, 2026: 45Oct 11, 2026: 45Oct 12, 2026: 45Oct 13, 2026: 43Oct 14, 2026: 43Oct 15, 2026: 42Oct 16, 2026: 40Oct 17, 2026: 41Oct 18, 2026: 41Oct 19, 2026: 41Oct 20, 2026: 42Oct 21, 2026: 45Oct 22, 2026: 41Oct 23, 2026: 43Oct 24, 2026: 43Oct 25, 2026: 43Oct 26, 2026: 42Oct 27, 2026: 44Oct 28, 2026: 44Oct 29, 2026: 44Oct 30, 2026: 42Nov 1, 2026: 42Nov 2, 2026: 42Nov 3, 2026: 45Nov 4, 2026: 47Nov 5, 2026: 43Nov 6, 2026: 45Nov 7, 2026: 45Nov 10, 2026: 44Nov 11, 2026: 47Nov 12, 2026: 32Nov 13, 2026: 34Nov 14, 2026: 34Nov 15, 2026: 33Nov 16, 2026: 32Nov 17, 2026: 31Nov 18, 2026: 31Nov 19, 2026: 30
Show the daily numbers
DateComposite
Nov 19, 202630
Nov 18, 202631
Nov 17, 202631
Nov 16, 202632
Nov 15, 202633
Nov 14, 202634
Nov 13, 202634
Nov 12, 202632
Nov 11, 202647
Nov 10, 202644
Nov 7, 202645
Nov 6, 202645
Nov 5, 202643
Nov 4, 202647
Nov 3, 202645
Nov 2, 202642
Nov 1, 202642
Oct 30, 202642
Oct 29, 202644
Oct 28, 202644
Oct 27, 202644
Oct 26, 202642
Oct 25, 202643
Oct 24, 202643
Oct 23, 202643
Oct 22, 202641
Oct 21, 202645
Oct 20, 202642
Oct 19, 202641
Oct 18, 202641
Oct 17, 202641
Oct 16, 202640
Oct 15, 202642
Oct 14, 202643
Oct 13, 202643
Oct 12, 202645
Oct 11, 202645
Oct 10, 202645
Oct 9, 202645
Oct 8, 202643
Oct 7, 202644
Oct 6, 202646
Oct 5, 202646
Oct 4, 202645
Oct 3, 202645
Oct 2, 202645
Oct 1, 202644
Sep 30, 202646
Sep 29, 202648
Sep 28, 202647
Sep 27, 202646
Sep 26, 202646
Sep 25, 202645
Sep 24, 202646
Sep 23, 202647
Sep 22, 202646
Sep 21, 202648
Sep 20, 202647
Sep 19, 202647
Sep 18, 202647
Sep 17, 202648
Sep 16, 202647
Sep 15, 202647
Sep 14, 202645
Sep 13, 202646
Sep 12, 202646
Sep 11, 202646
Sep 10, 202646
Sep 9, 202645
Sep 8, 202648
Sep 7, 202648
Sep 6, 202648
Sep 5, 202648
Sep 4, 202647
Sep 2, 202647
Sep 1, 202646
Aug 31, 202645
Aug 30, 202647
Aug 29, 202647
Aug 28, 202646
Aug 27, 202648
Aug 26, 202648
Aug 25, 202647
Aug 24, 202648
Aug 23, 202648

Key facts

Market cap
$1.0B
Sector
Healthcare
Industry
Biotechnology
Beta
1.29
Risk grade (1–10)
—
Next earnings
Nov 19, 2026

Questions

What is DRTS's stock rating today?

DRTS scores 30/100 (Bearish) as of Nov 19, 2026: technical 47, fundamental 26, and news sentiment 58, which is shown but not counted. Scores are recomputed every night.

What does Alpha Tau Medical do?

Alpha Tau Medical (DRTS) is an Israel-based medical device company developing Alpha DaRT, a cancer treatment that delivers alpha radiation directly inside solid tumors. Small radioactive sources implanted in the tumor release atoms that diffuse a short distance and emit alpha particles meant to destroy cancer cells while limiting harm to healthy tissue.

Is DRTS stock a buy?

The score is not a buy or sell recommendation. A 30 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the DRTS score calculated?

88 weighted scorers feed it today: 26 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

DRTS stock score

HTML

<a href="https://stocksscores.com/stocks/drts/"><img src="https://stocksscores.com/stocks/drts/badge.svg" alt="DRTS stock score" height="20"></a>

Markdown

[![DRTS stock score](https://stocksscores.com/stocks/drts/badge.svg)](https://stocksscores.com/stocks/drts/)